π₯ $9.2 BILLION MEGA-DEAL DETONATES: Merck Just Swallowed Cidara Therapeutics Whole β Stock More Than DOUBLED Overnight! Is CDTX About to Mint Millionaires? π°ππ₯
Asset of the week Cidara Therapeutics ( $Cidara Therapeutics(CDTX)$ )
Cidara stock blasted off from $108 to $218 +105% in days β one of the wildest biotech moves of 2025! ππ₯
Why the insane surge π€― Merck dropped a monster $9.2 BILLION all-cash acquisition bomb, scooping up Cidara to grab its late-stage influenza drug candidate (positive Phase 3 NAVIGATE topline already in the bag π). This isn't just a partnership β it's a full takeover that instantly validates Cidara's entire pipeline and catapults the stock to 9-year highs! ππ¦ Merck diversifying into antivirals right before flu season? Absolute chess move βοΈ
Whatβs next for CDTX? π Deal slated to close Q1 2026 β stock will likely hug the takeover price with juicy merger-arb premium. Regulatory green light almost certain (late-phase asset, clean data). Any positive updates on ANCHOR trial or integration news = fresh fuel for another leg up! β¬οΈβ¬οΈβ¬οΈ Analysts already hiking targets north of $230β$250 π₯
Why trade CDTX right now? β‘ Volatility is absolutely nuclear β 8-15% swings daily, perfect for scalps, breakouts, and pullback entries! Merger arb players piling in + retail FOMO = continued fireworks π
Example trade in FX mode: Deposit: $100 Trade amount: $50 Leverage: 20x If price moves just 6%: $50 Γ 6% Γ 20 = $60 profit (+120% on the trade!) π€π€π€
Whatβs your forecast? β CDTX keeps mooning to $250+ before close π β Profit-taking pulls it back 15-20% first π
Drop your vote and tag a friend who needs to see this rocket! ππ
π’ Like, repost, and follow for daily updates on market trends and stock insights.
π Disclaimer: This post is for informational purposes only and does not constitute financial advice. Always conduct your own research before making investment decisions.
π@Daily_Discussion @Tiger_comments @TigerStars @TigerEvents @TigerWire @CaptainTiger @MillionaireTiger
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- blinkiΒ·2025-11-20Next stop $250! This rocket's fueled for takeoff. πLikeReport
- Megan BarnardΒ·2025-11-21How much can ANCHOR trial updates really boost a taken-over stock?LikeReport
- Wade ShawΒ·2025-11-21Isnβt retail FOMO chasing a done deal just asking for a pullback?LikeReport
- Ron AnneΒ·2025-11-21Overnight fees + 20x leverage make scalping risky but rewarding!LikeReport